Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
Gestational diabetes mellitus is one of the most frequent complications of pregnancy, that
affect between 1 to 14% of population around the world.
There is a few studies to prevent gestational diabetes mellitus in high risk women as Mexican
population.
Metformin has been used during pregnancy in women with gestational diabetes and women with
polycystic ovary syndrome, with acceptable security for mother and fetus.
Metformin decrease the insulin resistance and weight gain, we believe that metformin may be
decrease the risk of gestational diabetes mellitus in high risk women.
Phase:
Phase 4
Details
Lead Sponsor:
Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
Collaborator:
National Council of Science and Technology, Mexico